Suvretta Capital Management, Llc - Sep 26, 2024 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director, 10%+ Owner
Signature
Suvretta Capital Management, LLC; By: /s/Andrew Nathanson , General Counsel & Chief Compliance Officer
Stock symbol
BNTC
Transactions as of
Sep 26, 2024
Transactions value $
$21,135,373
Form type
4
Date filed
9/30/2024, 05:17 PM
Previous filing
May 2, 2024
Next filing
Nov 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNTC Common stock, par value $0.0001 per share Exercise of in-the-money or at-the-money derivative security $1.14M +588K +40.01% $1.93 2.06M Sep 26, 2024 See footnotes F1, F2
transaction BNTC Common stock, par value $0.0001 per share Exercise of in-the-money or at-the-money derivative security $17.8M +4.61M +223.72% $3.86 6.66M Sep 26, 2024 See footnotes F1, F3
transaction BNTC Common stock, par value $0.0001 per share Exercise of in-the-money or at-the-money derivative security $122 +1.22M +18.31% $0.00 7.88M Sep 26, 2024 See footnotes F1, F4
transaction BNTC Common stock, par value $0.0001 per share Exercise of in-the-money or at-the-money derivative security $2.22M +576K +260.66% $3.86 797K Sep 26, 2024 See footnotes F1, F5
transaction BNTC Common stock, par value $0.0001 per share Exercise of in-the-money or at-the-money derivative security $14.80 +148K +18.59% $0.00 946K Sep 26, 2024 See footnotes F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Series 2 Common Warrants Exercise of in-the-money or at-the-money derivative security $0 -10M -100% $0.00 0 Sep 26, 2024 Common Stock 588K $1.93 See footnotes F1, F2
transaction BNTC Common Warrants Exercise of in-the-money or at-the-money derivative security $0 -4.61M -100% $0.00 0 Sep 26, 2024 Common Stock 4.61M $3.86 See footnotes F1, F3
transaction BNTC Pre-Funded Warrants Exercise of in-the-money or at-the-money derivative security $0 -1.22M -26.49% $0.00 3.39M Sep 26, 2024 Common Stock 4.61M $0.00 See footnotes F1, F4, F7
transaction BNTC Common Warrants Exercise of in-the-money or at-the-money derivative security $0 -576K -100% $0.00 0 Sep 26, 2024 Common Stock 576K $3.86 See footnotes F1, F5
transaction BNTC Pre-Funded Warrants Exercise of in-the-money or at-the-money derivative security $0 -148K -25.72% $0.00 428K Sep 26, 2024 Common Stock 576K $0.00 See footnotes F1, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Notes are included on Exhibit 99.1.
F2 Notes are included on Exhibit 99.1.
F3 Notes are included on Exhibit 99.1.
F4 Notes are included on Exhibit 99.1.
F5 Notes are included on Exhibit 99.1.
F6 Notes are included on Exhibit 99.1.
F7 Notes are included on Exhibit 99.1.

Remarks:

Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature